Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neovascular Age-related Macular Degeneration (nAMD)”

135 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 135 results

Not applicableEnded earlyNCT05266495
What this trial is testing

Effectiveness of Brolucizumab in Pre-treated Patients With nAMD in the Real-world Setting

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3
Testing effectiveness (Phase 2)Looking for participantsNCT05769153
What this trial is testing

Study of AR-14034 in Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Alcon Research 140
Post-approval studies (Phase 4)Active Not RecruitingNCT06795048
What this trial is testing

Determine the Efficacy, Safety, and Durability of Faricimab in Participants With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Hoffmann-La Roche 274
Not applicableLooking for participantsNCT04985487
What this trial is testing

Regulatory Post-Marketing Surveillance Study for Brolucizumab

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 3,000
Early research (Phase 1)Study completedNCT04635800
What this trial is testing

Evaluate the Safety, Tolerability and Pharmacokinetics of IVT MHU650 in Macular Edema Patients

Who this might be right for
Macular EdemaDiabetic Macular EdemaNeovascular Age-related Macular Degeneration+1 more
Novartis Pharmaceuticals 21
Large-scale testing (Phase 3)Active Not RecruitingNCT06491914
What this trial is testing

A Phase 3b, Single-Arm Study of Aflibercept 8 mg Dosed Every 4 Weeks in Adult Participants With Neovascular Age-Related Macular Degeneration (nAMD) or Diabetic Macular Edema (DME)

Who this might be right for
Neovascular Age-Related Macular DegenerationDiabetic Macular Edema
Regeneron Pharmaceuticals 1,118
Large-scale testing (Phase 3)Looking for participantsNCT06864988
What this trial is testing

4D-150 in Patients With Macular Neovascularization Secondary to Age-Related Macular Degeneration

Who this might be right for
Macular Neovascularization Secondary to Age-Related Macular Degeneration
4D Molecular Therapeutics 480
Testing effectiveness (Phase 2)Looking for participantsNCT06141460
What this trial is testing

Safety and Efficacy of RRG001 Gene Therapy in Subjects With Neovascular Age-related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-related Macular Degeneration
Shanghai Refreshgene Technology Co., Ltd. 48
Not applicableStudy completedNCT04632056
What this trial is testing

A 52-weeks Observational Study to Evaluate the Safety of Brolucizumab in Patients With nAMD

Who this might be right for
Neovascular Age-related Macular Degeneration
Novartis Pharmaceuticals 329
Not applicableStudy completedNCT06495203
What this trial is testing

Understand the Usage of an Artificial Intelligence Technology Called DARWEN for Eye Disorders and to Find Out the Factors Influencing Treatment Frequencies in People With nAMD and RVO

Who this might be right for
Neovascular Age-related Macular DegenerationRetinal Vein Occlusion
Bayer 1,350
Early research (Phase 1)Not Yet RecruitingNCT06623279
What this trial is testing

Open-laBel Dose-escalation Study for CRISPR/cas13- Rna TargetInG THerapy for the Treatment of Neovascular Age-related Macular Degeneration in Phase I Trial

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
HuidaGene Therapeutics Co., Ltd. 15
Testing effectiveness (Phase 2)Looking for participantsNCT06487039
What this trial is testing

Trial to Evaluate the Safety and Efficacy of EB-203 in Patients With Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
EyebioKorea, Inc. 50
Post-approval studies (Phase 4)Study completedNCT05941715
What this trial is testing

Faricimab for High-frequent Aflibercept Treated Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Medical University of Graz 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT06116890
What this trial is testing

Study to Assess the Efficacy & Safety of KHK4951 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
Kyowa Kirin Co., Ltd. 180
Not applicableUnknownNCT03893474
What this trial is testing

Quality-Assured Follow-up of Quiescent Neovascular Age -Related maculaR dEgeneration by Non-medical Practitioners

Who this might be right for
AMD
Moorfields Eye Hospital NHS Foundation Trust 742
Not applicableStudy completedNCT04543331
What this trial is testing

Observational Study to Evaluate Fluid Resolution and Effectiveness in Patients Receiving Beovu in Neovascular Age-related Macular Degeneration and Visual Impairment Due to Diabetic Macular Edema

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)Diabetic Macular Edema (DME)
Novartis Pharmaceuticals 572
Large-scale testing (Phase 3)Study completedNCT05161806
What this trial is testing

Study of the Safety of Use of Intravitreal SOK583A1 Provided in a Prefilled Syringe

Who this might be right for
Neovascular Age-related Macular Degeneration (nAMD)
Sandoz 30
Not applicableActive Not RecruitingNCT06075147
What this trial is testing

The SPECTRUM Study: An Observational Study to Learn More About How Well Aflibercept 8 mg Works in Treating Visual Impairment Due to Neovascular Age-related Macular Degeneration or Diabetic Macula Edema

Who this might be right for
Visual ImpairmentNeovascular Age-related Macular Degeneration (nAMD)Diabetic Macula Edema (DME)
Bayer 2,500
Not applicableLooking for participantsNCT06346600
What this trial is testing

A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD

Who this might be right for
Neovascular (Wet) Age-related Macular Degeneration
Skyline Therapeutics 83
Large-scale testing (Phase 3)Study completedNCT03823287
What this trial is testing

Evaluate the Efficacy and Safety of Faricimab in Participants With Neovascular Age-Related Macular Degeneration (TENAYA)

Who this might be right for
Wet Macular Degeneration
Hoffmann-La Roche 671
Load More Results